Filing metadata

Accession number
0001209191-23-034445
Form type
Form 4
Filer
Kinnate Biopharma Inc.
CIK
CIK 1797768
Filed
Jun 05, 2023
Reporting period
Jun 01, 2023
Description
Insider transaction

Explore SEC Filings Hub